on OXURION (EBR:OXUR)
Oxurion Reports Shareholding Changes by Atlas Special Opportunities
Oxurion NV, a biopharmaceutical company based in Leuven, announced that it received transparency notifications from Atlas Special Opportunities II, LLC. As of June 27, 2025, Atlas held 394,213 shares of Oxurion, dropping below the 5% threshold by selling voting securities. Furthermore, Atlas reported on July 1, 2025, that its holdings decreased to 26,211 shares, crossing under the 3% threshold.
The notifications are in line with Belgian Transparency legislation, which mandates the disclosure of significant changes in shareholding. These transactions highlight the dynamic nature of shareholder composition in biopharmaceutical ventures.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news